ZYUS Life Sciences Raises C$ 200,000 in First Tranche of Private Placement
Bitget2026/10/22 01:26- Zyus Life Sciences closed the first tranche of its non-brokered private placement on Oct. 21, 2026, raising CAD 200,000.
- Insiders purchased all 444,444 units issued at CAD 0.45 each.
- The offering targets up to CAD 3 million through 6,666,666 units; another tranche is expected to close shortly.
- Each unit comprises one common share and half a warrant, exercisable at CAD 0.59 per share for 24 months from issuance.
- Proceeds will fund general corporate and working capital purposes.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Jensen Huang's influence surpasses that of Nvidia— and that's exactly the problem
Jensen Huang has been the key driving force behind the massive expansion of AI infrastructure, with his personal credibility and authoritative decision-making deeply embedded in the narrative of the global tech market’s rise over the past three years. Now, as scandals emerge, Nvidia’s trading team is expected to become more conservative and slow down external financing commitments, which undoubtedly worsens the situation for neoclouds already facing tight funding.
Deutsche Bank made significant Q3 purchases of midstream AI application stocks: the three major cloud giants saw increased holdings, with Palantir (PLTR.US) and Salesforce (CRM.US) also favored.
Deutsche Bank has submitted its third quarter 13F holdings report for the period ending September 30, 2026.
Crypto prices
More
